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Parkinson’s disease (PD) is a debilitating neurodegenerative 
disorder with no known cure. PD is prevalent in approximately 
1% of individuals aged >65 years, increasing to 4% in individuals 
aged >80 years.1 In a study of the most populous countries in 
Western Europe and the world (including Germany, France, 
Nigeria and Japan), the number of PD-affected individuals in 
2005 was estimated to be 4.1 - 4.6 million. This figure is expected 
to double by 2030.2 PD epidemiological data are not available for 
South Africa (SA). 
PD aetiology is not fully understood, but is thought to involve 
an interaction between genetic and environmental risk factors.3 
Important insights into genetic causes have been made, largely due to 
the discovery of causative mutations in several genes.4
PD cases can be subcategorised based on age at onset (AAO): 
early-onset PD (EOPD) with an AAO ≤50 years, and late-onset PD 
(LOPD) with an AAO >50 years.5 EOPD and LOPD differ in clinical 
presentation and underlying genetic aetiology. EOPD exhibits a 
slower disease progression, a good response to levodopa therapy and 
additional signs such as dystonia and prominent levodopa-induced 
dyskinesias.6 Mutations in causative genes that are inherited in an 
autosomal recessive manner (e.g. parkin and PINK1) are associated 
with familial EOPD, whereas autosomal dominant mutations (in 
SNCA and LRRK2) typically contribute to familial LOPD.4
Although old age is a significant risk factor for PD, additional 
factors include a positive family history and environmental elements 
such as drinking well-water, living in a rural area, farming and 
pesticide exposure.7 Exposure to the insecticide rotenone,8 the 
herbicide paraquat9 and the neurotoxin 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)10 have been shown experimentally to 
cause mitochondrial dysfunction and subsequent parkinsonism 
in laboratory animals. Studies investigating PD associations with 
chemical products, such as metals, solvents, paints and other 
chemicals, have shown conflicting findings.11 Notably, cigarette 
smoking and coffee consumption are thought to protect against PD 
development.12,13 
We aimed to identify factors influencing EOPD and LOPD 
development in a group of 397 PD patients in SA.
Methods
The study was approved by the Committee for Human Research at 
the University of Stellenbosch (2002/C059). A total of 397 unrelated 
PD patients were recruited, with written informed consent, from the 
Movement Disorders Clinic at Tygerberg Hospital, a tertiary referral 
hospital in Cape Town, and through the Parkinson’s Association 
of SA. PD diagnosis was made by a movement disorder specialist 
according to the UK Parkinson’s Disease Society Brain Bank Research 
criteria. Participants were recruited as part of ongoing genetics 
research investigating the underlying genetic basis of PD in different 
ethnic groups in SA.
Recruited ethnic groups14 included white (288; 72.5%), coloured 
(86; 21.7%), black (18; 4.5%) and Indian/Asian (5; 1.3%). Ethnicity 
was self-reported. White Afrikaner patients were analysed 
separately to the ‘non-Afrikaner’ white patients. The Afrikaner 
population originated in SA and descended from a group of 2 000 
mainly male progenitors who arrived in the Cape in the 17th and 
18th centuries;15 they were predominantly of Dutch, German and 
French origin. Initially, due to cultural, religious and language 
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Background. Neurodegenerative disorders such as Parkinson’s 
disease (PD) contribute significantly to global disease burden. PD 
can be categorised into early-onset PD (EOPD) with an age at onset 
(AAO) of ≤50 years and late-onset PD (LOPD) with an AAO of 
>50 years.
Aims. To identify factors influencing EOPD and LOPD 
development in a group of patients in South Africa (SA).
Methods. A total of 397 unrelated PD patients were recruited 
from the Movement Disorders Clinic at Tygerberg Hospital and 
via the Parkinson’s Association of SA. Patient demographic and 
environmental data were recorded and associations with PD onset 
(EOPD v. LOPD) were analysed with a Pearson’s Chi-squared test. 
The English- and Afrikaans-speaking (Afrikaner) white patients 
were analysed separately.
Results. Logistic regression analysis showed that ethnicity (p<0.001) 
and family history (p=0.004) were independently associated with 
AAO of PD. Average AAO was younger in black, coloured and 
Afrikaner patients than English-speaking white patients. A positive 
family history of PD, seen in 31.1% of LOPD patients, was associated 
with a younger AAO in the study population.
Conclusions. These associations may be attributed to specific genetic 
and/or environmental risk factors that increase PD susceptibility and 
influence the clinical course of the disorder. More studies on PD in 
the unique SA populations are required to provide novel insights into 
mechanisms underlying this debilitating condition. 
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differences, the Afrikaner population remained largely isolated. 
Indicative of their unique ancestral lineage, several rare inherited 
disorders such as porphyria variegata and Gaucher’s disease 
occur at unusually high frequencies in this population, possibly 
due to genetic founder effects.16 The coloured ethnic group is an 
admixture of indigenous African, European, South Asian and 
Indonesian populations.17
Sampled clinical data included AAO and family history of PD; 
the latter defined as having ≥1 family member (first-, second- or 
third-degree relative) with possible PD. Environmental data for 
each index patient, collected with a questionnaire, were recorded as 
part of a collaboration with the international Genetic Epidemiology 
of Parkinson’s Disease (GEO-PD) Consortium. Information was 
obtained on current and previous occupation, smoker status, coffee 
consumption and pesticide exposure prior to PD diagnosis. Optional 
responses were ‘ever’ or ‘never’; ‘ever’ was defined as having smoked 
≥1 cigarette per day, consumed ≥1 cup of coffee per day, and broadly, 
as the use of a  herbicide, fungicide or insecticide, prior to PD onset.
Data were analysed descriptively, using means and standard 
deviations for continuous data and frequencies counts and 
percentages for categorical data. Associations between AAO (binary 
classification: ≤50 years of age v. >50 years of age) and demographic 
and environmental variables were analysed with a Pearson’s Chi-
squared test. In cases of small cell frequencies, a Fisher’s Exact test 
was used to assess association. A multiple logistic regression was used 
to test the association between demographic variables and AAO after 
adjusting for the presence of other predictor variables. Where the 
actual (continuous) AAO was analysed, a Student’s t-test was used. A 
significance level of 5% was applied throughout.
Results
A total of 397 patients were recruited over a 5-year period (2007 - 
2011) (Table 1); 62.5% (248) were male and 34.8% (138) had a family 
history of PD. For the first 3.5 years, the study focussed mainly on 
recruiting EOPD patients and/or those with a positive family history 
of PD (as these were thought to harbour a greater genetic component). 
Subsequent to the identification of mutations associated with LOPD, 
criteria also included LOPD and sporadic (non-familial) cases. 
A significant association was found between AAO and ethnicity; the 
black, coloured and white Afrikaner patients had a younger mean AAO 
than the ‘non-Afrikaner’ whites (p=0.00038) (Table 1 and Fig. 1). The 
black patients exhibited the youngest AAO but were limited in numbers 
(n=18); this finding requires verification. A positive family history was 
associated with a younger AAO (p=0.01445). No association was 
found between AAO and gender or an environmental factor (cigarette 
smoking, coffee drinking, pesticide use and chemical exposure) (Table 
Table 1. Patient demographic and clinical characteristics (N=397)
EOPD
n (%)
LOPD
n (%) p-value
Gender (N=397) 0.70145
Male (n=248) 71 (64.0) 177 (61.9)
Female (n=149) 40 (36.0) 109 (38.1)
Ethnic group (N=397) 0.00038
White (‘non-Afrikaner’) (n=167) 27 (24.3) 140 (49.0)
White (Afrikaner) (n=121) 44 (39.7) 77 (26.9)
Coloured (n=86) 30 (27.0) 56 (19.6)
Black (n=18) 8 (7.2) 10 (3.5)
Indian (n=5) 2 (1.8) 3 (1.0)
Family history of PD (N=397) 0.01445
Yes (n=138) 49 (44.1) 89 (31.1)
No (n=259) 62 (55.9) 197 (68.9)
Environmental factors*
Cigarette smoking (N=283) 0.28642
Ever (n=107) 17 (31.5) 90 (39.3)
Never (n=176) 37 (68.5) 139 (60.7)
Coffee drinking (N=283) 0.40860
Ever (n=213) 43 (79.6) 170 (74.2)
Never (n=70) 11 (20.4) 59 (25.8)
Pesticide use (N=278) 0.85839
Ever (n=88) 17 (32.7) 71 (31.4)
Never (n=190) 35 (67.3) 155 (68.6)
Chemical exposure (N=280) 0.27767
Yes (n=160) 35 (63.6) 125 (55.6)
No (n=120) 20 (36.4) 100 (44.4)
* Data were not available for all 397 participants (not all completed questionnaires).
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1). This may be attributed to small sample sizes; relevant data were not 
available for every participant. Logistic regression analysis showed that 
ethnicity and family history were independently associated with AAO 
(p<0.001 and p=0.004, respectively).  Mean AAO was 56.8 years (SD 
±12.4; 95% CI 55.6 - 58.0, range 17 - 87) (Fig. 2), emphasising that PD 
also occurs in comparatively young individuals. 
A positive family history was found in 31.1% of LOPD patients 
(Table 1). This may be an underestimate: one LOPD patient 
(individual III-1; Fig 3) initially reported no family history. However, 
we previously identified a disease-causing mutation (R1441C in 
the LRRK2 gene) in the patient (unpublished data), which led to a 
subsequent family follow-up. A sibling of the patient (individual III-
5) was shown to harbour the mutation and later clinically diagnosed 
with PD; the sibling reported 2 other possibly affected individuals 
who were deceased (individuals II-1 and II-2). 
Discussion
This study raises awareness about the relatively high frequency of 
PD cases with young onset and a positive family history among SA 
patients. This retrospective investigation demonstrated that the black, 
white Afrikaner and coloured patients had a younger AAO than 
‘non-Afrikaner’ white patients. A positive family history was also 
associated with a younger AAO. These associations may be attributed 
to specific genetic and/or environmental risk factors that increase PD 
susceptibility and influence the clinical course of the disorder.
Approximately one-third of LOPD patients exhibited positive 
family histories, challenging the assumption that LOPD manifests 
sporadically, and demonstrating a possible genetic contribution. We 
contend that positive family histories are often underreported and, 
consequently, underestimated. The initial analysis of family history of 
PD may be misleading unless further intensive follow-up and genetic 
work-up of the families is performed. 
In this study, gender had no effect on AAO, in accordance with 
the literature.18 However, 62.5% of patients were male, possibly due 
to recruitment bias. Some studies have shown that men are 1.5 times 
more likely to develop PD than females.19 However, this trend is not 
consistent across studies.
We found no significant association between cigarette smoking, 
coffee drinking, pesticides or hazardous chemicals exposure with 
AAO of PD, despite work by others showing the contribution of 
these factors to PD susceptibility.13,20 Exposure to environmental risk 
factors may increase PD susceptibility without necessarily affecting 
AAO. A lack of exposure data for unaffected control individuals 
precluded any tests for such an association.
Study limitations include the relatively small samples sizes 
(particularly for the black group) and a lack of environmental variable 
data for every participant. Furthermore, recruitment bias may have 
been introduced, although it is unclear what influence this may have 
had on participant AAO. Study patients were part of an ongoing 
research project investigating PD genetic aetiology; they were recruited 
from a tertiary academic centre and various PD support groups of 
the Parkinson’s Association of SA. Coloured patients were recruited 
primarily from Tygerberg Hospital, ‘non-Afrikaner’ white patients were 
recruited predominantly from support groups, and white Afrikaners 
were recruited almost equally from both sources. 
Conclusion
There is little knowledge on the environmental and genetic factors 
associated with PD in SA. Although our findings are preliminary, 
studies on unique and diverse SA populations are needed to provide 
novel insights into the risk factors and pathogenesis underlying this 
debilitating disorder. 
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Stellenbosch.Fig. 2. Distribution of AAO of PD among patients (N=397).
Fig. 3. Pedigree of a SA family with PD. The individuals are depicted as 
diamond symbols; filled-in symbols indicate PD-affected individuals. 
The arrow designates the index case. A line through the diamond symbol 
denotes a deceased individual. R1441C het = individual heterozygous for the 
R1441C mutation in the LRRK2 gene.
Fig. 1. Box and whisker plots of patient AAO of PD v. ethnicity. Data are 
represented as means. 
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South Africa has the highest rates of fetal alcohol spectrum disorders 
(FASD) in the world, with rates of over 70/1 000 in the Western Cape, 
one of the worst affected areas globally.1 In contrast, rates of 0.33 - 2.2/1 
000 have been reported for the US population.1 Despite numerous 
intervention efforts, the prevalence of FASD is increasing.1 Depression 
and anxiety in pregnancy consistently predict women who continued 
to use alcohol and substances in pregnancy2 and those who were high-
risk drinkers antenatally.3 Depression may serve as both an initiating 
and a maintaining factor for alcohol and substance use in pregnancy. 
To our knowledge, there are no published South African data 
on both alcohol and substance use in pregnancy, or the effects of 
antenatal depression (AND) on alcohol and substance use. Women in 
low- and middle-income countries have rates of postnatal depression 
(PND) comparable to and often higher than their counterparts in 
the developed world.4,5 Meta-analyses have shown that depression 
Objectives. To study the prevalence of alcohol and substance use in 
a South African antenatal population and its correlates with socio-
demographic factors, depression and perceived stress.
Methods. A prospective self-report study on all women presenting 
for their first antenatal visit who consented to the study at a midwife 
obstetric unit (MOU) in the East Metropole district, Cape Town, 
using the Alcohol Use Disorders Identification Test (AUDIT), Drug 
Use Disorders Identification Test (DUDIT), Edinburgh Depression 
Scale (EDS) and Perceived Stress Scale (PSS). Statistical analyses 
using the chi-square test, separate one-way analyses of variance 
(ANOVA) and logistic regression analyses were performed as 
appropriate. Outcome measures were depression, alcohol use and 
substance use.
Results. The questionnaire was completed by 323 women. During 
pregnancy 36.8% of women smoked, 20.2% used alcohol and 
4% used substances. Using EDS cut-off scores of 12 and 15, 
respectively, 48.9% and 33.6% of the sample had scores consistent 
with major depression. An EDS cut-off score of 12 was significantly 
associated with both alcohol use (25.9% v. 15.2%, p=0.019) and 
risky drinking (76.9% v. 36.8%, p=0.04), while an EDS cut-off score 
of 15 was significantly associated with substance use (8.2% v. 1.4%, 
p=0.004) as well as alcohol dependence (23.1% v. 3.1%).
Conclusions. We found high rates of both alcohol abuse and 
antenatal depression, and a significant association between 
depression, substance use and alcohol abuse; EDS scores greater 
than 12 could be used to identify women at risk of alcohol 
dependence and/or substance abuse.
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during pregnancy is an important risk factor for PND,6 yet few data 
are available on AND. 
In South Africa there has been, to our knowledge, only one 
published study of antenatal depression,7 which found a 40% rate 
of AND in a study of rural women from KwaZulu-Natal. This is 
of particular concern, as not only is AND a potent risk factor for 
PND, but it is associated with significant distress. AND has been 
associated with poor obstetric outcomes including preterm labour, 
intra-uterine growth restriction and low birth weight.8 High rates of 
AND therefore constitute a significant public health problem, and 
more data on its prevalence are important in planning appropriate 
interventions.
A relationship has been shown between higher perceived stress 
and increased risk of AND and PND.9 Higher perceived stress is also 
associated with an increased risk of relapse after smoking cessation 
interventions in pregnancy.10 There are no studies examining the 
relationship between perceived stress and alcohol or substance use 
in pregnancy. However, in non-pregnant women with alcohol and/or 
substance use disorders, perceived stress is associated with increased 
use and increased risk of relapse.11 South African pregnant women 
have high levels of perceived stress,12 and this may modulate their risk 
of depression and substance use.
We therefore examined the prevalence and correlates of substance 
use, depression and perceived stress in a South African antenatal 
population.
Methods
All women over the age of 18 presenting for their first antenatal 
visit at a midwife obstetric unit (MOU) in the East Metropole 
district, Cape Town, during March 2008 were asked to participate. 
Subjects who consented completed a self-report questionnaire 
comprising a demographic and lifestyle questionnaire, the Alcohol 
Use Disorders Identification Test (AUDIT), the Drug Use Disorders 
Identification Test (DUDIT), the Edinburgh Depression Scale (EDS), 
and the Perceived Stress Scale (PSS). It was administered by a 
research assistant in a private room adjacent to the main clinic. 
To accommodate participants with limited literacy, the research 
assistant read out questions. All women gave informed consent 
for participation. Ethical approval was obtained from the ethics 
committee of Stellenbosch University. 
The demographic and lifestyle questionnaire was designed for 
the study and collected demographic data (age, marital status, income 
and level of education), data on past pregnancies and current and 
past smoking.
The Edinburgh Depression Scale (EDS)13 is a 10-item self-report 
scale, validated antenatally and postnatally,14 that is the most accepted 
measure of depression in pregnancy and the puerperium. The 
validated15 cut-off score for South African populations is 12. However, 
it has been proposed that a higher cut-off score of 15 is more 
appropriate for women in pregnancy.16 We used both cut-off scores. 
The Perceived Stress Scale (PSS)17 is a 4-item self-report scale used 
to assess perceived stress, including factors of being overwhelmed 
and feeling out of control. 
The Alcohol Use Disorders Identification Test (AUDIT)18 is a 
10-item screening instrument designed to identify drinkers at risk for 
alcohol abuse and dependence. Scores above 6 indicate risky drinking 
and above 20 indicates alcohol dependence.
The Drug Use Disorders Identification Test (DUDIT)19 is an 
11-item self-report questionnaire, which looks at frequency of drug 
use. A cut-off score of 2 indicates drug-related problems and 25 or 
more probable drug dependence.
Descriptive analyses were performed as appropriate. Subjects 
scoring above the EDS cut-off scores were compared with those 
scoring below these cut-points. The chi-square test and separate 
one-way analyses of variance (ANOVA) were used to examine 
differences in demographic factors and in smoking, alcohol use, 
drug use and perceived stress. Logistic regression analyses were 
performed to determine whether EDS scores and demographic 
factors could distinguish patients using alcohol and drugs from 
those who did not use them. Alpha for the item entry was set at 
0.01 and alpha for the item removal entry at 0.05. Finally, a receiver 
operating characteristic curve (ROC) analysis was performed. The 
area under the ROC curve (AUC) indicates a particular scale’s 
diagnostic ability to discriminate between individuals with and 
without a particular diagnosis20.
Results 
The questionnaire was completed by 323 women (98% of eligible 
subjects). Their mean age was 24.6 years (SD 5.5); 88.3% were coloured, 
9.8% black, 1.5% white and 0.3% Indian; and 139 (43.9%) were 
primiparous. The mean gestational age was 15.5 weeks (standard 
deviation (SD) 6.9), with 42.4% in the first trimester of pregnancy, 
48.9% in the second trimester and 8.7% in the third trimester. Most 
women (37.7%) described themselves as single, 25.2% were married, 
20.2% lived with their partner but were not married, a further 16.0% 
had a partner but did not live with them, and 0.3% was divorced; 46% 
were employed.
Smoking, alcohol and substance use. Of the women, 116 (36.8%) 
smoked, 66 (20.2%) used alcohol and 13 (4%) used substances at the 
time of their first antenatal visit; 126 (40.4%) smoked, 115 (35.3%) 
used alcohol and 18 (5.5%) used substances in the periconceptual 
period (in the 3 months before they found out that they were 
pregnant). Periconceptual alcohol use was significantly associated with 
alcohol use in pregnancy (54.8% v. 1.4%, p<0.001), and periconceptual 
substance use was similarly significantly associated with substance use 
in pregnancy (50% v. 1.3%, p<0.0001). Of the 66 women using alcohol 
in pregnancy, 58 completed the AUDIT; their mean AUDIT score 
during pregnancy was 10.4 (SD 7.1). Of the 58 women who completed 
the AUDIT, 7 scored above 20. As only 6 women completed the full 
DUDIT questionnaire the DUDIT data were not analysed.
Depression and stress. The mean score for the EDS was 12.6 (SD 
6.3) and that for the PSS 8.1 (SD 3.3). Using EDS cut-off scores of 12 
and 15, respectively, 48.9% and 33.6% of the sample had antenatal 
depression. There was a significant positive correlation between 
the EDS and PSS total scores (r=0.195, p<0.001). There were no 
significant differences in age, marital status, employment, parity 
and gestational age at booking between women with depression 
and women without depression (as determined using both cut-off 
scores). 
Associations between depression, stress and smoking, alcohol 
and other substances. There was a significant positive correlation 
between the total EDS score and drug use (0.111, p=0.0 47) and with 
alcohol use (0.180, p=0.001).The EDS total score was also significantly 
positively correlated with the total AUDIT score (0.29, p=0.022). 
An EDS cut-off score of 12 was significantly associated with both 
alcohol use (25.9% of women with a score above 12 used alcohol 
v. 15.2% of women scoring below 12; p=0.019) and risky drinking 
(76.9% scoring above 12 had scores indicative of risky drinking v. 
36.8% of women with a score below 12; p=0.04). In contrast, an EDS 
cut-off score of 15 was significantly associated with substance use 
(8.2% of women scoring above 15 used substances v. 1.4% of women 
who scored below 15; p=0.004) as well as alcohol dependence (23.1% 
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of women who scored above 15 had alcohol dependence v. 3.1% of 
women who scored below 15, p=0.038). 
Owing to sample size limitations, logistic regression analysis was 
only performed for alcohol use in pregnancy. Periconceptual alcohol 
use here emerged as the only predictor of continued alcohol use 
during pregnancy (odds ratio (OR) 4.522, p=0.000). 
The ROC analysis for alcohol use in pregnancy showed an AUC of 
0.583 for an EDS cut-off score of 12, 0.553 for an EDS cut-off score 
of 15, and 0.876 for periconceptual alcohol use (Fig. 1). The ROC 
analysis for substance use in pregnancy showed an AUC of 0.636 
for an EDS cut-off score of 12, 0.712 for an EDS cut-off score of 15, 
and 0.819 for periconceptual substance use (Fig. 2). Table 1 presents 
sensitivity and specificity scores. 
No associations between smoking and depression (using either 
EDS cut-off score) were found. Similarly, no associations between the 
PSS and smoking, alcohol and substance use were found. 
Discussion
Our main findings were: (i) high rates of both alcohol abuse 
and antenatal depression; (ii) a significant association between 
depression, substance use and alcohol abuse; (iii) that many women 
using alcohol and/or substances stop use once they discover they are 
pregnant; and (iv) that EDS scores above 12 can be used to identify 
women at risk of alcohol dependence and/or substance use.
This study confirms previous findings of high rates of antenatal 
depression in a sample of South African women.7 However, the 
extremely high prevalence using an EDS cut-off score of 12 (almost 
50%) raises the concern that this cut-off point may not be valid in the 
South African population. A score of 15 may be a better identifier of 
depression, and the EDS cut-off scores for pregnant South African 
women should be revalidated. However, even when using a higher 
cut-off score, the 30% rate of depression found is a cause for concern. 
Furthermore, the EDS and PSS were highly correlated, suggesting 
that even if the EDS over-identifies depression, pregnant women in 
this sample are significantly distressed. 
The high rates of alcohol use found during pregnancy and in the 
periconceptual period are consistent with studies of FAS prevalence1 
and alcohol and substance use in women of reproductive age.21 It 
is important to note that almost half the women who use alcohol 
spontaneously stop use once they discover they are pregnant. 
Furthermore, most of those who continue to drink despite falling 
pregnant exhibit risky drinking behaviour. This is of particular 
concern as it indicates that these infants are at high risk of developing 
FASD and their mothers are likely to have increased difficulty in 
providing appropriate parenting.
The high rates of smoking and substance use in these subjects 
are further indicators of a population at high risk of poor obstetric 
outcomes and child developmental problems. 
The high co-morbidity between depression and alcohol and 
substance use is in keeping with studies of non-pregnant women.22 
This is important for several reasons. Firstly, it shows that these 
women experience a significant burden of disease. In women 
who are not pregnant, combined interventions addressing both 
depression and alcohol/substance are most effective. This study 
suggests that this may also be true for pregnant women. Finally, 
under-reporting of alcohol and substance use in pregnancy is 
common. Women may be more likely to admit to depressive 
symptoms or alcohol/substance use before pregnancy than to 
current use. Periconceptual use and the presence of antenatal 
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Fig. 2. Predictors of substance use in pregnancy.
Fig. 1. Predictors of alcohol use in pregnancy.
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Table 1. Sensitivity and specificity scores (%)
Alcohol use in pregnancy Substance use in pregnancy
Sensitivity Specificity Sensitivity Specificity
EDS cut-off score 12 62.1 54.5 75.0 52.3
EDS cut-off score 15 42.4 68.1 75.0 67.4
Periconceptual alcohol use 95.5 79.8 - -
Periconceptual substance use - - 66.7 99.9
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depression may be therefore used as a proxy measure to identify 
women at risk for alcohol/substance use, and serve as a starting 
point to build a therapeutic alliance in which substance and alcohol 
issues can be explored further.
Indeed the regression and ROC analyses show that both 
periconceptual use and an EDS score of more than 12 can be used 
as a screening tool to identify women at high risk of alcohol and 
substance dependence. The EDS is a quick self-report screen that 
is used in busy antenatal clinics with minimal additional burden on 
the staff. Screening for depression and risk of alcohol and substance 
use disorders could therefore potentially be accomplished using the 
EDS and one question around periconceptual use without needing 
additional staff time or training, factors that are often cited as barriers 
to screening.
Limitations of the study
This study was conducted at two MOUs in Cape Town. It is not 
known whether these results are generalisable to other areas and 
populations. Furthermore, the Western Cape is known to be an area 
where alcohol and substance abuse is rife. Whether the EDS could 
be used to identify women at risk for alcohol and substance use in 
populations with a lower prevalence of these disorders is not known. 
The study also relied on self-report data, which were not verified by 
a diagnostic interview or laboratory tests. There may therefore be 
under- or over-reporting of depression, alcohol and substance use 
disorders. Subjects were also examined at one time point only. We 
therefore cannot predict any changes in behaviour during the course 
of pregnancy. 
Conclusion
Alcohol, substance use and depression occur frequently in 
pregnant women and pose a significant public health problem. 
Periconceptual alcohol and substance use and antenatal 
depression are key risk factors for alcohol and substance abuse 
during pregnancy. Screening for depression and periconceptual 
use is therefore important to identify and treat women with 
antenatal depression and to identify women at risk for alcohol and 
substance use in pregnancy. The high co-morbidity between these 
conditions also suggests that combined interventions addressing 
both alcohol and substance use and depression may be needed to 
adequately treat these women.
Acknowledgements. The authors thank Katherine Sorsdahl and Henri 
Carrera for their help with statistical analysis.
References
1. May PA, Gossage JP, Marais AS, et al. The epidemiology of fetal alcohol syndrome and partial FAS in a 
South African community. Drug Alcohol Depend 2007;88(2-3):259-271. [http://dx.doi.org/10.1016/j.
drugalcdep.2006.11.007]
2. Meschke LL, Hellerstedt W, Holl JA, Messelt S. Correlates of prenatal alcohol use. Matern Child Health 
J 2008;12(4):442-451. [http://dx.doi.org/10.1007/s10995-007-0261-9]
3. Homish GG, Cornelius JR, Richardson GA, Day NL. Antenatal risk factors associated with postpartum 
comorbid alcohol use and depressive symptomatology. Alcohol Clin Exp Res 2004;28(8):1242-1248. 
[http://dx.doi.org/10.1097/01.ALC.0000134217.43967.97]
4. Tomlinson M, Cooper PJ, Stein A, Swartz L, Molteno C. Post-partum depression and infant growth 
in a South African peri-urban settlement. Child Care Health Dev 2006;32(1):81-86. [http://dx.doi.
org/10.1111/j.1365-2214.2006.00598.x]
5. Husain N, Bevc I, Husain M, Chaudhry IB, Atif N, Rahman A. Prevalence and social correlates of 
postnatal depression in a low income country. Arch Womens Ment Health 2006;9(4):197-202. [http://
dx.doi.org/10.1007/s00737-006-0129-9]
6. Beck CT. A meta-analysis of predictors of postpartum depression. Nurs Res 1996;45(5):297-303. 
[http://dx.doi.org/10.1097/00006199-199609000-00008]
7. Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A. Depression among pregnant 
rural South African women undergoing HIV testing. JAMA 2006;295(12):1376-1378. [http://dx.doi.
org/10.1001/jama.295.12.1376]
8. Koubovec D, Geerts L, Odendaal HJ, Stein DJ, Vythilingum B. Effects of psychologic stress on fetal 
development and pregnancy outcome. Curr Psychiatry Rep 2005;7(4):274-280. [http://dx.doi.
org/10.1007/s11920-005-0081-9]
9. Karacam Z, Ancel G. Depression, anxiety and influencing factors in pregnancy: a study 
in a Turkish population. Midwifery 2009;25(4):344-356. [http://dx.doi.org/10.1016/j.
midw.2007.03.006]
10. Park ER, Chang Y, Quinn V, et al. The association of depressive, anxiety, and stress symptoms and 
postpartum relapse to smoking: A longitudinal study. Nicotine Tob Res 2009;11(6):707-714. [http://
dx.doi.org/10.1093/ntr/ntp053]
11. Fouquereau E, Fernandez A, Mullet E, Sorum PC. Stress and the urge to drink. Addict Behav 
2003;28(4):669-685. [http://dx.doi.org/10.1016/S0306-4603(01)00276-3]
12. Vythilingum B, Geerts L, Fincham D, et al. Association between antenatal distress and uterine artery 
pulsatility index. Arch Womens Ment Health 2010;13(4):359-364. [http://dx.doi.org/10.1007/s00737-
010-0144-8]
13. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh 
Postnatal Depression Scale. Br J Psychiatry 1987;150:782-786. [http://dx.doi.org/10.1192/bjp.150.6.782]
14. Peindl KS, Wisner KL, Hanusa BH. Identifying depression in the first postpartum year: guidelines 
for office-based screening and referral. J Affect Disord 2004;80(1):37-44. [http://dx.doi.org/10.1016/
S0165-0327(03)00052-1]
15. Lawrie TA, Hofmeyr GJ, de Jager M, Berk M. Validation of the Edinburgh Postnatal Depression Scale 
on a cohort of South African women. S Afr Med J 1998;88(10):1340-1344. 
16. Matthey S, Henshaw C, Elliott S, Barnett B. Variability in use of cut-off scores and formats on the 
Edinburgh Postnatal Depression Scale: implications for clinical and research practice. Arch Womens 
Ment Health 2006;9(6):309-315. [http://dx.doi.org/10.1007/s00737-006-0152-x]
17. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 
1983;24(4):385-396. 
18. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification 
Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur 
Addict Res 2005;11(1):22-31. [http://dx.doi.org/10.1159/000081413]
19. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation 
of a screening instrument for use in medical settings. J Stud Alcohol 1995;56(4):423-432. [http://
dx.doi.org/10.1016/j.jsat.2003.09.005]
20. Hanley JA, McNeil BJ. The meaning of the use of the area under a receiver operating characteristic 
(ROC) curve. Radiology 1982;143(1):29-36. 
21. Ojo OA, Louwagie G, Morojele N, et al. Factors associated with female high-risk drinking in a rural 
and an urban South African site. S Afr Med J 2010;100(3):180-182. 
22. Schuckit MA, Daeppen JB, Tipp JE, Hesselbrock M, Bucholz KK. The clinical course of alcohol-related 
problems in alcohol dependent and nonalcohol dependent drinking women and men. J Stud Alcohol 
1998;59(5):581-590. 
